Systemic therapy options in malignant bone diseases

Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2005, Vol 7, Issue 5

Abstract

Bone metastases (secondary bone neoplasms) represent a more significant epidemiological problem than primary bone neoplasms. The differing histogenesis of primary and secondary malignant bone neoplasms (respectively, mesenchymal and epithelial origin) influences the variability of activity and indications for systemic therapy. A common response is the use of systemic therapy within a multidisciplinary therapeutic approach. The principles of chemotherapy used for primary bone neoplasms are essentially similar in spindle-cell and small-cell sarcomas. Initial multi-drug chemotherapy should be administered in all stages. Chemotherapy may also be used following local treatment, although the role of adjuvant chemotherapy is better defined in small-cell sarcomas. Chemotherapy is also applied in the palliative management of disseminated sarcomas.Systemic therapy plays an essential role in the management of patients with bone metastases during the course of breast and prostate carcinoma. The use of hormonal therapy is based on endocrine dependency of both malignancies. Chemotherapy represents a treatment of choice in several clinical situations due to high chemosensitivity of the underlying malignancy (e. g., small-cell lung cancer or lymphoma). Bisphosphonates play an important role in the management of bone metastases. The use of bisphosphonates is most justified in patients with breast cancer, multiple myeloma, and prostate carcinoma.

Authors and Affiliations

Maciej Krzakowski

Keywords

Related Articles

Tłumaczenie, adaptacja kulturowa i walidacja polskojęzycznej wersji kwestionariusza Foot and Ankle Outcomes Questionnaire

Wstęp. W polskojęzycznej literaturze brak jest narzędzia umożliwiającego pomiar wyników leczenia w obrębie stawu skokowego i stopy na podstawie opinii pacjentów.Materiał i metody. Dokonano zgodnego z zaleceniami przekład...

The Oxford II medial unicompartmental knee replacement. A minimum 10-year follow-up study

Background. The first clinical results from unicondylar knee arthroplasty (UKA), which was introduced in the early seventies, were non-conclusive. The development and modernization of unicompartmental implants (mobile be...

Evaluation of the Effectiveness of Preoperative Physiotherapy Using the Lysholm-Gillquist Scale in Patients Qualified for Surgical Arthroscopic Anterior Cruciate Ligament Reconstruction - Pilot Study

Background. Recent years have seen a noticeable increase in the number of people experiencing total damage to the anterior cruciate ligament in the knee joint. The causes are many, but increased sporting activity among p...

Contemporary views on the ossification of the ligamenta flava

The ligamenta flava, together with the vertebral lamina, form the posterior wall of the spinal canal. Since they are located immediately adjacent to the nerve structures of the spinal cord, every pathology that involves...

The Modern Rehabilitation Medicine Enigma: Treating People with Disabilities, but Sometimes without a Clear Diagnosis

Background. The process of a comprehensive rehabilitation of the disabled person may be more complicated when the diagnosis becomes vague and uncertain. Unknown data about the patient’s past, mental, physical or vocation...

Download PDF file
  • EP ID EP56376
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

Maciej Krzakowski (2005). Systemic therapy options in malignant bone diseases. Ortopedia Traumatologia Rehabilitacja, 7(5), 567-572. https://europub.co.uk/articles/-A-56376